DETECTING GENETIC COPY NUMBER VARIATION

• US 20170009287A1
• Filed: 07/08/2015
• Published: 01/12/2017
• Est. Priority Date: 07/08/2015
• Status: Active Grant

• Current Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Original Assignee: Quest Diagnostics Investments Incorporated (Quest Diagnostics Incorporated)
• Inventors: Brastaad, Corey, Elzinga, Christopher D., Zhang, Mingsheng, Evans, Matthew C.
• Granted Patent: US 10,640,823 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor
• CPC Class Codes: C12Q 2531/113 PCR
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2537/16 Assays for determining copy number or wherein the copy number is of special importance

Abstract

Embodiments of the invention include systems, apparatus, and methods for detecting copy number variation (CNV) in the genomes of one or more patients. Samples of DNA may be taken from several patients, and then sections of the patients'"'"' DNA may be sequenced, e.g., through a process that may include, for each patient, one or more of: purifying, concentrating, fragmenting, labeling, filtering, and amplifying that patient'"'"'s DNA. Fragments from several patients may be pooled, and the fragments in the pool may be sequenced.

The sequencing data is then subjected to analysis, which includes several normalization steps. The normalized data are then examined to identify CNV, which is reported.

Claims

1. A method of detecting copy number variation (CNV) in the DNA of a plurality of patients, the method comprising:

receiving a plurality of samples, each sample containing DNA from a single patient;

from each sample, generating a plurality of fragments of DNA;

barcoding each of the fragments with an identifier that uniquely identifies the respective patient from whom the DNA was received;

pooling the plurality of samples into a DNA library;

subjecting the DNA library to one or more stages of filtering to increase the relative concentration of fragments within a plurality of selected regions of interest;

producing sequencing data for the plurality of patients by sequencing the filtered DNA library;

demultiplexing the sequencing data;

for each patient, generating coverage data by identifying, for each of the regions of interest, coverage of each region of interest in the sequencing data;

generating normalized coverage data from the coverage data;

generating reference coverage, common to all samples, for each region of interest, the generation of the reference coverage being based upon the normalized coverage data;

automatically detecting CNV for at least one subsequence of at least one of the regions of interest of at least one of the patients based upon comparing the reference coverage to the normalized coverage data; and

providing output that identifies the patient, the subsequence, and the CNV.

2. The method of claim 1, wherein generating normalized coverage data from the coverage data comprises:

generating raw coverage data for each patient by at least generating an estimate of the number of the patient'"'"'s X chromosomes based on the coverage data and scaling the patient'"'"'s coverage of at least one region of interest that is known to be X-linked; and

generating normalized coverage data from the raw coverage data.

3. The method of claim 2, wherein generating the estimate of the number of each patient'"'"'s X chromosomes occurs without reference to any demographic information about the respective patient and without reference to any information about the respective patient'"'"'s phenotype.

4. The method of claim 2, comprising:

for each patient, generating a second estimate of the number of the patient'"'"'s X chromosomes based on the normalized coverage data; and

revising the normalized coverage data based on the second estimates.

5. The method of claim 4, wherein generating the second estimate of the number of each patient'"'"'s X chromosomes occurs without reference to any demographic information about the respective patient and without reference to any information about the respective patient'"'"'s phenotype.

6. The method of claim 2, wherein:

the coverage data comprises per-base coverage for each region of interest within the sequencing data;

generating raw coverage data comprises scaling the patient'"'"'s per-base coverage of the at least one region of interest that is known to be X-linked;

the normalized coverage data comprises per-base coverage;

the reference coverage comprises per-base coverage for each position within each region of interest; and

automatically detecting CNV is based upon the per-base reference coverage and the normalized coverage data.

7. The method of claim 1, wherein each region of interest corresponds respectively to exactly one exon and contains that exon.

8. The method of claim 7, comprising:

automatically detecting CNV for a plurality of adjacent exons within a gene of a patient, each of the adjacent exons having the same CNV; and

automatically rolling up the CNV of the adjacent exons.

9. The method of claim 8, comprising:

automatically detecting CNV for all exons within a gene of a patient, each of the exons within the gene having the same CNV; and

automatically rolling up the CNV of the exons within the gene into a single CNV for the gene.

10. The method of claim 7, comprising subjecting the DNA library to one or more stages of amplification, such that each region of interest is an amplicon.

11. The method of claim 1, wherein:

the coverage data comprises per-base coverage for each region of interest within the sequencing data;

the normalized coverage data comprises per-base coverage;

the reference coverage comprises per-base coverage for each position within each region of interest; and

automatically detecting CNV is based upon the per-base reference coverage and the normalized coverage data.